Nuveen
OFIX icon

Nuveen’s Orthofix Medical OFIX Stock Holding History

Nuveen’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.71M Buy
186,793
+13,059
+8% +$144K ﹤0.01% 2656
2026
Q1 		$1.99M Sell
173,734
-158,308
-48% -$2.09M ﹤0.01% 2282
2025
Q4 		$5.03M Sell
332,042
-203,230
-38% -$3.1M ﹤0.01% 1900
2025
Q3 		$7.84M Buy
535,272
+458,040
+593% +$6.01M ﹤0.01% 1688
2025
Q2 		$861K Sell
77,232
-11,388
-13% -$141K ﹤0.01% 2677
2025
Q1 		$1.45M Hold
88,620
– – ﹤0.01% 2470
2024
Q4 		$1.55M Sell
88,620
-36,392
-29% -$633K ﹤0.01% 2492
2024
Q3 		$1.95M Sell
125,012
-151,914
-55% -$2.43M ﹤0.01% 2423
2024
Q2 		$3.67M Buy
276,926
+67,109
+32% +$920K ﹤0.01% 2098
2024
Q1 		$3.05M Sell
209,817
-53,476
-20% -$739K ﹤0.01% 2200
2023
Q4 		$3.55M Buy
263,293
+42,633
+19% +$501K ﹤0.01% 2133
2023
Q3 		$2.84M Sell
220,660
-3,417
-2% -$61.5K ﹤0.01% 2147
2023
Q2 		$4.05M Hold
224,077
– – ﹤0.01% 2031
2023
Q1 		$3.75M Buy
224,077
+83,661
+60% +$1.64M ﹤0.01% 2046
2022
Q4 		$2.88M Buy
140,416
+873
+0.6% +$15.4K ﹤0.01% 2217
2022
Q3 		$2.67M Sell
139,543
-12,321
-8% -$277K ﹤0.01% 2247
2022
Q2 		$3.58M Sell
151,864
-69,593
-31% -$1.99M ﹤0.01% 2147
2022
Q1 		$7.1M Sell
221,457
-731
-0.3% -$23.5K ﹤0.01% 1858
2021
Q4 		$6.41M Sell
222,188
-7,524
-3% -$252K ﹤0.01% 1965
2021
Q3 		$8.76M Sell
229,712
-13,909
-6% -$554K ﹤0.01% 1873
2021
Q2 		$9.77M Sell
243,621
-3,276
-1% -$138K ﹤0.01% 1887
2021
Q1 		$10.7M Sell
246,897
-9,421
-4% -$415K ﹤0.01% 1749
2020
Q4 		$11M Sell
256,318
-74,350
-22% -$2.72M ﹤0.01% 1650
2020
Q3 		$10.3M Sell
330,668
-191,805
-37% -$5.95M ﹤0.01% 1498
2020
Q2 		$16.7M Buy
522,473
+107,925
+26% +$3.58M 0.01% 1156
2020
Q1 		$11.6M Buy
414,548
+10,119
+3% +$391K 0.01% 1206
2019
Q4 		$18.7M Sell
404,429
-38,793
-9% -$1.82M 0.01% 1211
2019
Q3 		$23.5M Buy
443,222
+14,809
+3% +$764K 0.01% 1041
2019
Q2 		$22.7M Buy
+428,413
New +$22.8M 0.01% 1083

Other funds holding OFIX

ECM
Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Nuveen's OFIX Position: Q2 2026 in Review

Nuveen increased its Orthofix Medical (OFIX) stake by 7.5% in Q2 2026, buying an estimated $144K and bringing the position to 186,793 shares worth $1.71M. The position accounts for ﹤0.01% of the portfolio, ranked #2656.

Nuveen first reported a position in OFIX in Q2 2019 and has held it in 29 quarters since. The position peaked at $23.5M in Q3 2019. 143 funds tracked by Wall St. Rank hold OFIX as of Q2 2026.

  • Nuveen held 186,793 shares of Orthofix Medical worth $1.71M as of Q2 2026.
  • Nuveen bought 13,059 Orthofix Medical shares in Q2 2026, an estimated $144K.
  • Orthofix Medical made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2656 holding.
  • Nuveen first reported a position in Orthofix Medical in Q2 2019 and has held it in 29 quarters since.
  • Nuveen's Orthofix Medical position peaked at $23.5M in Q3 2019.
  • 143 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.